Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Mundy

Showing results (141-150 of 292) with videos related to

Pageof 30
Sort By:
Calcified Tissue International|May 1, 1983
The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancyD A Sica, R R Martodam, J Aronow, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitroT A Guise, T Yoneda, A J Yates, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1991
Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclastsA J Yates, R O Oreffo, K Mayor, et al.
The American Journal of Medicine|October 1, 1978
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapyG R Mundy, M E Rick, R Turcotte, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal miceM Sabatini, B Boyce, T Aufdemorte, et al.
Clinical Pharmacology and Therapeutics|April 1, 1976
Sodium salicylamide: relative bioavailability and subjective effectsL Fleckenstein, G R Mundy, R A Horovitz, et al.
Endocrinology|August 1, 1991
Differentiation of HL-60 cells into cells with the osteoclast phenotypeT Yoneda, M M Alsina, J L Garcia, et al.
Journal of the American Society of Nephrology : JASN|August 1, 1991
Altered renal calcium handling in hypercalcemia of malignancyK R Tuttle, R T Kunau, N Loveridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 4, 1998
Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cellsR Nishimura, K Moriyama, K Yasukawa, et al.
The Journal of Cell Biology|August 1, 1984
Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cellsK J Ibbotson, G D Roodman, L M McManus, et al.
Pageof 30

Showing results (141-150 of 292) with videos related to

Sort By:
Pageof 30
Calcified Tissue International|May 1, 1983
The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancyD A Sica, R R Martodam, J Aronow, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitroT A Guise, T Yoneda, A J Yates, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1991
Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclastsA J Yates, R O Oreffo, K Mayor, et al.
The American Journal of Medicine|October 1, 1978
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapyG R Mundy, M E Rick, R Turcotte, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal miceM Sabatini, B Boyce, T Aufdemorte, et al.
Clinical Pharmacology and Therapeutics|April 1, 1976
Sodium salicylamide: relative bioavailability and subjective effectsL Fleckenstein, G R Mundy, R A Horovitz, et al.
Endocrinology|August 1, 1991
Differentiation of HL-60 cells into cells with the osteoclast phenotypeT Yoneda, M M Alsina, J L Garcia, et al.
Journal of the American Society of Nephrology : JASN|August 1, 1991
Altered renal calcium handling in hypercalcemia of malignancyK R Tuttle, R T Kunau, N Loveridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 4, 1998
Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cellsR Nishimura, K Moriyama, K Yasukawa, et al.
The Journal of Cell Biology|August 1, 1984
Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cellsK J Ibbotson, G D Roodman, L M McManus, et al.
Pageof 30